Here we used a similar approach to set up a non-radioactive cell-based method using 2-NBDG in COS-7 monkey kidney cells, as well as SKOV3 human ovarian cancer cells that overexpress GLUT1, to evaluate and validate 75 potential GLUT1 inhibitors. Here, SLC2A1 is linked to ovarian carcinoma.